BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21613307)

  • 1. The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in Mycobacterium smegmatis.
    Castañeda-García A; Do TT; Blázquez J
    J Antimicrob Chemother; 2011 Jul; 66(7):1489-98. PubMed ID: 21613307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis.
    Siu GK; Zhang Y; Lau TC; Lau RW; Ho PL; Yew WW; Tsui SK; Cheng VC; Yuen KY; Yam WC
    J Antimicrob Chemother; 2011 Apr; 66(4):730-3. PubMed ID: 21393153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wag31 protein interacts with AccA3 and coordinates cell wall lipid permeability and lipophilic drug resistance in Mycobacterium smegmatis.
    Xu WX; Zhang L; Mai JT; Peng RC; Yang EZ; Peng C; Wang HH
    Biochem Biophys Res Commun; 2014 Jun; 448(3):255-60. PubMed ID: 24792177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
    Alexander DC; Jones JR; Liu J
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
    Afanas'ev MV; Ikryannikova LN; Il'ina EN; Sidorenko SV; Kuz'min AV; Larionova EE; Smirnova TG; Chernousova LN; Kamaev EY; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.
    Khara JS; Wang Y; Ke XY; Liu S; Newton SM; Langford PR; Yang YY; Ee PL
    Biomaterials; 2014 Feb; 35(6):2032-8. PubMed ID: 24314557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana.
    Homolka S; Meyer CG; Hillemann D; Owusu-Dabo E; Adjei O; Horstmann RD; Browne EN; Chinbuah A; Osei I; Gyapong J; Kubica T; Ruesch-Gerdes S; Niemann S
    Int J Med Microbiol; 2010 Nov; 300(7):489-95. PubMed ID: 20538518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis.
    McNeil MB; Dennison D; Parish T
    Microbiology (Reading); 2017 Jul; 163(7):1065-1070. PubMed ID: 28703701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rifampicin & isoniazid on cytochrome P-450 in mycobacteria.
    Ramachandran G; Gurumurthy P
    Indian J Med Res; 2002 Oct; 116():140-4. PubMed ID: 12674827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs.
    Ren H; Liu J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):250-5. PubMed ID: 16377694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in
    Do TT; Rodríguez-Beltran J; Cebrián-Sastre E; Rodríguez-Rojas A; Castañeda-García A; Blázquez J
    Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Mycobacterium tuberculosis resistance mutations to rifampin and isoniazid by real-time PCR.
    Hristea A; Otelea D; Paraschiv S; Macri A; Baicus C; Moldovan O; Tinischi M; Arama V; Streinu-Cercel A
    Indian J Med Microbiol; 2010; 28(3):211-6. PubMed ID: 20644308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct role of formamidopyrimidine DNA glycosylase (MutM) in down-regulation of accumulation of G, C mutations and protection against oxidative stress in mycobacteria.
    Jain R; Kumar P; Varshney U
    DNA Repair (Amst); 2007 Dec; 6(12):1774-85. PubMed ID: 17698424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of an RNA polymerase interacting protein, MsRbpA, from Mycobacterium smegmatis in phenotypic tolerance to rifampicin.
    Dey A; Verma AK; Chatterji D
    Microbiology (Reading); 2010 Mar; 156(Pt 3):873-883. PubMed ID: 19926651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.